CARDIO DIAGNOSTICS HOLDINGS (CDIO)
US14159C1036 - Common Stock
CARDIO DIAGNOSTICS HOLDINGS
NASDAQ:CDIO (11/22/2024, 8:00:02 PM)
After market: 0.2659 +0 (+0.19%)0.2654
+0.02 (+7.28%)
Company Profile
Cardio Diagnostics Holdings, Inc. engages in the provision of medical diagnostic testing services. The company is headquartered in Chicago, Illinois and currently employs 7 full-time employees. The company went IPO on 2021-11-23. The firm develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.
Company Info
CARDIO DIAGNOSTICS HOLDINGS
311 W. Superior Street, Suite 444
Chicago ILLINOIS
P: 18552269991
Employees: 7
Website: http://www.cardiodiagnosticsinc.com
CDIO News
11 days ago - Cardio Diagnostics Holdings, Inc.Cardio Diagnostics Holdings, Inc. to Sponsor and Showcase AI-Powered Solutions at the FLAACOs Annual Conference2 months ago - Cardio Diagnostics Holdings, Inc.Cardio Diagnostics Holdings, Inc. Receives Preliminary Medicare Pricing from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests3 months ago - InvestorPlaceCDIO Stock Earnings: Cardio Diagnostics Hldgs Beats EPS, Misses Revenue for Q2 2024CDIO stock results show that Cardio Diagnostics Hldgs beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
3 months ago - BusinessInsiderCDIO Stock Earnings: Cardio Diagnostics Hldgs Beats EPS, Misses Revenue for Q2 2024InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cardio Diagnostics Hldgs (NASDAQ:CDIO) just reported results for the second qua...
4 months ago - Cardio Diagnostics Holdings, Inc.Cardio Diagnostics Holdings Inc. Launches CDIO.AI, A Redesigned Website Enhancing User Experience and Highlighting Our AI-Driven Cardiovascular Solutions5 months ago - Cardio Diagnostics Holdings, Inc.Cardio Diagnostics Announces Its Epi+Gen CHD Heart Attack Risk Assessment Test is Now Available at Meijer Supercenter in McHenry, IllinoisCDIO Twits
Here you can normally see the latest stock twits on CDIO, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
